Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.6221 USD | +3.32% | +3.32% | -37.79% |
2023 | EV Biologics, Inc. Closes A $500,000 Interest-Free Loan | CI |
2023 | Ev Biologics Completes Production of Cutting-Edge Msc Exosome-Based Therapeutic | CI |
Financials (USD)
Sales 2016 | 42.64M | Sales 2017 | 9.51M | Capitalization | 6.09M |
---|---|---|---|---|---|
Net income 2016 | -53M | Net income 2017 | -7M | EV / Sales 2016 | 0.69 x |
Net Debt 2016 | 9M | Net Debt 2017 | 10.03M | EV / Sales 2017 | 1.7 x |
P/E ratio 2016 |
-0.38
x | P/E ratio 2017 |
-0.82
x | Employees | - |
Yield 2016 * |
-
| Yield 2017 |
-
| Free-Float | 23.58% |
1 day | +3.32% | ||
1 week | +3.32% | ||
1 month | +3.32% | ||
3 months | -11.39% | ||
6 months | -43.95% | ||
Current year | -37.79% |
Managers | Title | Age | Since |
---|---|---|---|
Daniel McKinney
CEO | Chief Executive Officer | 62 | 18-10-28 |
Jason Sanders
BRD | Director/Board Member | 46 | 20-08-30 |
William Bossung
BRD | Director/Board Member | - | 23-08-06 |
Members of the board | Title | Age | Since |
---|---|---|---|
Daniel McKinney
CEO | Chief Executive Officer | 62 | 18-10-28 |
William Bossung
BRD | Director/Board Member | - | 18-12-02 |
Jason Sanders
BRD | Director/Board Member | 46 | 20-08-30 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-09 | 0.6221 | +3.32% | 2,500 |
Delayed Quote OTC Markets, May 09, 2024 at 10:09 am EDT
More quotes1st Jan change | Capi. | |
---|---|---|
-37.79% | 6.36M | |
+23.60% | 50.56B | |
+9.98% | 16.62B | |
-2.71% | 15.93B | |
-10.44% | 11.08B | |
+32.69% | 9.27B | |
-2.99% | 7.77B | |
-4.45% | 7.73B | |
+39.80% | 7.68B | |
+105.28% | 7.64B |
- Stock Market
- Equities
- YECO Stock